Overactive Bladder and BPH clinical trial watch

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes U.S. phase II, III, and IV overactive bladder trials that are currently recruiting participants as well as phase II BPH trials. This list is current as of Feb. 16, 2011.

Overactive Bladder

• Combined Behavioral and Drug Treatment of OAB in MenSponsor(s): University of Alabama at Birmingham
Identifier: NCT01175382

• Hypnotherapy for Treatment of OABSponsor(s): University of New Mexico
Identifier: NCT00793611

• Solifenacin Succinate (VESIcare) for the Treatment of OAB in Parkinson's DiseaseSponsor(s): University of South Florida, Astellas Pharma Inc.
Identifier: NCT01018264

• Local Anesthetic Treatments for OABSponsor(s): NorthShore University HealthSystem Research Institute, Berlex Foundation
Identifier: NCT00427648

• A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive BladderSponsor(s): Pfizer
Identifier: NCT00928070

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.